Incyte (INCY) is a publicly traded Healthcare sector company. As of November 17, 2026, INCY trades at $120.19 with a market cap of $24.66B and a P/E ratio of 43.18. INCY moved -0.07% today. Year to date, INCY is +18.56%; over the trailing twelve months it is +15.45%. Its 52-week range spans $53.56 to $132.60. Analyst consensus is buy with an average price target of $134.37. Rallies surfaces INCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for INCY shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $120.19 |
| Market Cap | $24.66B |
| P/E Ratio | 43.18 |
| EPS | $2.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $132.60 |
| 52-Week Low | $53.56 |
| Volume | 534 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.70B |
| Net Income | $597.60M |
| Gross Margin | 93.10% |
21 analysts cover INCY: 0 strong buy, 10 buy, 11 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $134.37.